AnnJi files U.S. FDA application for Phase 3 AJ201 trial
AnnJi Pharmaceutical Co Ltd has submitted an application to the U.S. FDA for a Phase 3 clinical trial of AJ201.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.